Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 6
2005 8
2006 12
2007 11
2008 24
2009 32
2010 12
2011 23
2012 28
2013 24
2014 31
2015 25
2016 23
2017 34
2018 27
2019 24
2020 35
2021 48
2022 60
2023 63
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

506 results

Results by year

Filters applied: . Clear all
Page 1
Retraction Notice.
Hong Z, Yanfang J, Shumei H, Jie S, Qing G, Xiangwei F, Bing D, Wei W, Xiaodong S, Chunyan W, Siqi Z, Wanyu L, Junyan F, Junqi N. Hong Z, et al. Among authors: qing g. Turk J Gastroenterol. 2021 Nov;32(11):995. doi: 10.5152/tjg.2021.241121. Turk J Gastroenterol. 2021. PMID: 34872901 Free PMC article. No abstract available.
PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial.
Du J, Lu C, Mao L, Zhu Y, Kong W, Shen S, Tang M, Bao S, Cheng H, Li G, Chen J, Li Q, He J, Li A, Qiu X, Gu Q, Chen D, Qi C, Song Y, Qian X, Wang L, Qiu Y, Liu B. Du J, et al. Among authors: gu q. Cell Rep Med. 2023 Mar 21;4(3):100972. doi: 10.1016/j.xcrm.2023.100972. Epub 2023 Mar 7. Cell Rep Med. 2023. PMID: 36889321 Free PMC article. Clinical Trial.
Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy.
Yang S, Li T, Jia H, Gao M, Li Y, Wan X, Huang Z, Li M, Zhai Y, Li X, Yang X, Wang T, Liang J, Gu Q, Luo X, Qian L, Lu S, Liu J, Song Y, Wang F, Sun X, Yu D. Yang S, et al. Among authors: gu q. Sci Transl Med. 2022 Jun;14(647):eabj2177. doi: 10.1126/scitranslmed.abj2177. Epub 2022 Jun 1. Sci Transl Med. 2022. PMID: 35648811 Clinical Trial.
Non-lipid II targeting lantibiotics.
Wang X, Gu Q, Breukink E. Wang X, et al. Among authors: gu q. Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183244. doi: 10.1016/j.bbamem.2020.183244. Epub 2020 Feb 29. Biochim Biophys Acta Biomembr. 2020. PMID: 32126235 Free article. Review. No abstract available.
Rhodium-Catalyzed Asymmetric C-H Functionalization Reactions.
Liu CX, Yin SY, Zhao F, Yang H, Feng Z, Gu Q, You SL. Liu CX, et al. Among authors: gu q. Chem Rev. 2023 Aug 23;123(16):10079-10134. doi: 10.1021/acs.chemrev.3c00149. Epub 2023 Aug 1. Chem Rev. 2023. PMID: 37527349 Review.
Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
Xie F, Quan R, Zhang G, Tian H, Chen Y, Yu Z, Zhang C, Liu Y, Zhu X, Wu W, Zhu X, Yang Z, Gu Q, Xiong C, Han H, Cheng Y, He J, Wu Y. Xie F, et al. Among authors: gu q. J Heart Lung Transplant. 2023 Jul;42(7):974-984. doi: 10.1016/j.healun.2023.02.1494. Epub 2023 Feb 25. J Heart Lung Transplant. 2023. PMID: 37002152
506 results